866-997-4948(US-Canada Toll Free)

Global Budesonide Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 113 Pages

This report studies the global market size of Budesonide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Budesonide in these regions.
This research report categorizes the global Budesonide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.
Statistic for budesonide in this report includes three product types: nasal spray, inhaler and pill&rectal forms.

North America is the largest consumer in the past years. North America occupied more than 40% consumption market share in 2015. Europe is the second largest region around the world, it occupied about 34% consumption market share in 2015.
There are three type of budesonide product in the market: nasal sprayinhaler and pill&rectal forms. Inhaler has the largest output due to the large asthma treatment market.
AstraZeneca is the leading company in the budesonide market. Its revenue from budesonide is 1.3 billion USD in 2015, occupied more than half of global budesonide market.
In 2017, the global Budesonide market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Budesonide market based on company, product type, application and key regions.

The various contributors involved in the value chain of Budesonide include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Budesonide include
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical

Market Size Split by Type
Nasal Spray
Inhaler
Pill&Rectal Forms
Market Size Split by Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Budesonide market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Budesonide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Budesonide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Budesonide with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Budesonide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Budesonide are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Budesonide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Budesonide Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Budesonide Market Size Growth Rate by Type
1.4.2 Nasal Spray
1.4.3 Inhaler
1.4.4 Pill&Rectal Forms
1.5 Market by Application
1.5.1 Global Budesonide Market Size Growth Rate by Application
1.5.2 Respiratory Disease Treatment
1.5.3 Nose Disease Treatment
1.5.4 Inflammatory Bowel Disease Treatment
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Budesonide Market Size
2.1.1 Global Budesonide Revenue 2016-2025
2.1.2 Global Budesonide Sales 2016-2025
2.2 Budesonide Growth Rate by Regions
2.2.1 Global Budesonide Sales by Regions
2.2.2 Global Budesonide Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Budesonide Sales by Manufacturers
3.1.1 Budesonide Sales by Manufacturers
3.1.2 Budesonide Sales Market Share by Manufacturers
3.1.3 Global Budesonide Market Concentration Ratio (CR5 and HHI)
3.2 Budesonide Revenue by Manufacturers
3.2.1 Budesonide Revenue by Manufacturers (2016-2018)
3.2.2 Budesonide Revenue Share by Manufacturers (2016-2018)
3.3 Budesonide Price by Manufacturers
3.4 Budesonide Manufacturing Base Distribution, Product Types
3.4.1 Budesonide Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Budesonide Product Category
3.4.3 Date of International Manufacturers Enter into Budesonide Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Budesonide Sales by Type
4.2 Global Budesonide Revenue by Type
4.3 Budesonide Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Budesonide Breakdown Data by Application

6 North America
6.1 North America Budesonide by Countries
6.1.1 North America Budesonide Sales by Countries
6.1.2 North America Budesonide Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Budesonide by Type
6.3 North America Budesonide by Application
6.4 North America Budesonide by Company

7 Europe
7.1 Europe Budesonide by Countries
7.1.1 Europe Budesonide Sales by Countries
7.1.2 Europe Budesonide Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Budesonide by Type
7.3 Europe Budesonide by Application
7.4 Europe Budesonide by Company

8 Asia Pacific
8.1 Asia Pacific Budesonide by Countries
8.1.1 Asia Pacific Budesonide Sales by Countries
8.1.2 Asia Pacific Budesonide Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Budesonide by Type
8.3 Asia Pacific Budesonide by Application
8.4 Asia Pacific Budesonide by Company

9 Central & South America
9.1 Central & South America Budesonide by Countries
9.1.1 Central & South America Budesonide Sales by Countries
9.1.2 Central & South America Budesonide Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Budesonide by Type
9.3 Central & South America Budesonide by Application
9.4 Central & South America Budesonide by Company

10 Middle East and Africa
10.1 Middle East and Africa Budesonide by Countries
10.1.1 Middle East and Africa Budesonide Sales by Countries
10.1.2 Middle East and Africa Budesonide Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Budesonide by Type
10.3 Middle East and Africa Budesonide by Application
10.4 Middle East and Africa Budesonide by Company

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Budesonide
11.1.4 Budesonide Product Description
11.1.5 Recent Development
11.2 Cosmo Pharmaceuticals
11.2.1 Cosmo Pharmaceuticals Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Budesonide
11.2.4 Budesonide Product Description
11.2.5 Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Budesonide
11.3.4 Budesonide Product Description
11.3.5 Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Budesonide
11.4.4 Budesonide Product Description
11.4.5 Recent Development
11.5 Sandoz
11.5.1 Sandoz Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Budesonide
11.5.4 Budesonide Product Description
11.5.5 Recent Development
11.6 Dr. Falk Pharma
11.6.1 Dr. Falk Pharma Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Budesonide
11.6.4 Budesonide Product Description
11.6.5 Recent Development
11.7 Chiesi Farmaceutici S.p.A
11.7.1 Chiesi Farmaceutici S.p.A Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Budesonide
11.7.4 Budesonide Product Description
11.7.5 Recent Development
11.8 Orion Corporation
11.8.1 Orion Corporation Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Budesonide
11.8.4 Budesonide Product Description
11.8.5 Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Budesonide
11.9.4 Budesonide Product Description
11.9.5 Recent Development
11.10 Synmosa Biopharma Corporation
11.10.1 Synmosa Biopharma Corporation Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Budesonide
11.10.4 Budesonide Product Description
11.10.5 Recent Development
11.11 Lunan Better Pharmaceutical
11.12 Shanghai Sine Promod Pharmaceutical

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Budesonide Raw Material
13.1.2 Budesonide Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Budesonide
Figure Global Budesonide Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Budesonide Production Market Share by Types (Product Category) in 2017
Figure Nasal Spray Product Picture
Table Major Manufacturers of Nasal Spray
Figure Inhaler Product Picture
Table Major Manufacturers of Inhaler
Figure Pill&Rectal Forms Product Picture
Table Major Manufacturers of Pill&Rectal Forms
Table Global Budesonide Market Size Growth Rate by Application 2018-2025 (MT)
Figure Respiratory Disease Treatment
Figure Nose Disease Treatment
Figure Inflammatory Bowel Disease Treatment
Figure Budesonide Report Years Considered
Figure Global Budesonide Market Size 2016-2025 (Million US$)
Figure Global Budesonide Sales 2016-2025 (MT)
Table Global Budesonide Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Budesonide Sales by Regions 2016-2025 (MT)
Table Global Budesonide Sales Market Share by Regions 2016-2025
Figure Global Budesonide Sales Market Share by Regions 2016-2025
Figure 2017 Global Budesonide Sales Market Share by Regions
Table Global Budesonide Revenue by Regions 2016-2025 (Million US$)
Table Global Budesonide Revenue Market Share by Regions 2016-2025
Figure Global Budesonide Revenue Market Share by Regions 2016-2025
Figure 2017 Global Budesonide Revenue Market Share by Regions
Table Global Budesonide Sales by Manufacturers (2016-2018) (MT)
Table Global Budesonide Sales Share by Manufacturers (2016-2018)
Figure Global Budesonide Sales Share by Manufacturers in 2017
Table Budesonide Revenue by Manufacturers (2016-2018) (Million US$)
Table Budesonide Revenue Share by Manufacturers (2016-2018)
Figure Budesonide Value Share by Manufacturers in 2017
Table Global Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Budesonide Price (2016-2018) (USD/Kg)
Table Budesonide Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Budesonide Product Category
Table Date of International Manufacturers Enter into Budesonide Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Budesonide Sales by Type (2016-2025) (MT)
Table Global Budesonide Sales Share by Type (2016-2025)
Figure Global Budesonide Sales Market Share by Type (2016-2025)
Figure Global Budesonide Sales Market Share by Type in 2017
Table Global Budesonide Revenue by Type (2016-2025) (Million US$)
Table Global Budesonide Revenue Share by Type (2016-2025)
Figure Global Budesonide Revenue Market Share by Type (2016-2025)
Figure Global Budesonide Revenue Market Share by Type in 2017
Table Budesonide Price by Type 2013-2018 (USD/Kg)
Table Global Budesonide Sales by Application (2016-2025) (MT)
Table Global Budesonide Sales Share by Application (2016-2025)
Figure Global Sales Budesonide Market Share by Application (2016-2025)
Figure Global Sales Budesonide Market Share by Application (2016-2025)
Figure North America Budesonide Sales Growth Rate 2016-2025 (MT)
Figure North America Budesonide Revenue Growth Rate 2016-2025 (Million US$)
Table North America Budesonide Sales by Countries (2016-2025) (MT)
Table North America Budesonide Sales Market Share by Countries (2016-2025)
Figure 2017 North America Budesonide Sales Market Share by Countries
Table North America Budesonide Revenue by Countries (2016-2025) (Million US$)
Table North America Budesonide Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Budesonide Revenue Market Share by Countries
Figure United States Budesonide Sales Growth Rate (2016-2025) (MT)
Figure United States Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Canada Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Mexico Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Table North America Budesonide Sales by Type (2016-2025) (MT)
Table North America Budesonide Sales Market Share by Type (2016-2025)
Figure 2017 North America Budesonide Market Share by Type
Table North America Budesonide Sales by Application (2016-2025) (MT)
Table North America Budesonide Sales Market Share by Application (2016-2025)
Figure 2017 North America Budesonide Market Share by Application
Table North America Budesonide Sales by Company (2016-2018) (MT)
Table North America Budesonide Sales Market Share by Company (2016-2018)
Figure North America Budesonide Sales Market Share by Company in 2017
Figure Europe Budesonide Sales Growth Rate 2016-2025 (MT)
Figure Europe Budesonide Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Budesonide Sales by Countries (2016-2025) (MT)
Table Europe Budesonide Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Budesonide Sales Market Share by Countries
Table Europe Budesonide Revenue by Countries (2016-2025) (Million US$)
Table Europe Budesonide Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Budesonide Revenue Market Share by Countries
Figure Germany Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Germany Budesonide Revenue Growth Rate (2016-2025) (MT)
Figure France Budesonide Sales Growth Rate (2016-2025) (MT)
Figure France Budesonide Revenue Growth Rate (2016-2025) (MT)
Figure UK Budesonide Sales Growth Rate (2016-2025) (MT)
Figure UK Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Italy Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Russia Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Budesonide Sales by Type (2016-2025) (MT)
Table Europe Budesonide Sales Market Share by Type (2016-2025)
Figure 2017 Europe Budesonide Market Share by Type
Table Europe Budesonide Sales by Application (2016-2025) (MT)
Table Europe Budesonide Sales Market Share by Application (2016-2025)
Figure 2017 Europe Budesonide Market Share by Application
Table Europe Budesonide Sales by Company (2016-2018) (MT)
Table Europe Budesonide Sales Market Share by Company (2016-2018)
Figure Europe Budesonide Sales Market Share by Company in 2017
Figure Asia Pacific Budesonide Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Budesonide Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Budesonide Sales by Countries (2016-2025) (MT)
Table Asia Pacific Budesonide Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Budesonide Sales Market Share by Countries
Table Asia Pacific Budesonide Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Budesonide Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Budesonide Revenue Market Share by Countries
Figure China Budesonide Sales Growth Rate (2016-2025) (MT)
Figure China Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Japan Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Korea Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure India Budesonide Sales Growth Rate (2016-2025) (MT)
Figure India Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Australia Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Philippines Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Thailand Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Singapore Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Budesonide Sales by Type (2016-2025) (MT)
Table Asia Pacific Budesonide Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Budesonide Market Share by Type
Table Asia Pacific Budesonide Sales by Application (2016-2025) (MT)
Table Asia Pacific Budesonide Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Budesonide Market Share by Application
Table Asia Pacific Budesonide Sales by Company (2016-2018) (MT)
Table Asia Pacific Budesonide Sales Market Share by Company (2016-2018)
Figure Asia Pacific Budesonide Sales Market Share by Company in 2017
Figure Central & South America Budesonide Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Budesonide Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Budesonide Sales by Countries (2016-2025) (MT)
Table Central & South America Budesonide Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Budesonide Sales Market Share by Countries
Table Central & South America Budesonide Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Budesonide Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Budesonide Revenue Market Share by Countries
Figure Brazil Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Brazil Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Argentina Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Budesonide Sales by Type (2016-2025) (MT)
Table Central & South America Budesonide Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Budesonide Market Share by Type
Table Central & South America Budesonide Sales by Application (2016-2025) (MT)
Table Central & South America Budesonide Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Budesonide Market Share by Application
Table Central & South America Budesonide Sales by Company (2016-2018) (MT)
Table Central & South America Budesonide Sales Market Share by Company (2016-2018)
Figure Central & South America Budesonide Sales Market Share by Company in 2017
Figure Middle East and Africa Budesonide Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Budesonide Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Budesonide Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Budesonide Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Budesonide Sales Market Share by Countries
Table Middle East and Africa Budesonide Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Budesonide Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Budesonide Revenue Market Share by Countries
Figure GCC Countries Budesonide Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Turkey Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Budesonide Sales Growth Rate (2016-2025) (MT)
Figure Egypt Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Budesonide Sales Growth Rate (2016-2025) (MT)
Figure South Africa Budesonide Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Budesonide Sales by Type (2016-2025) (MT)
Table Middle East and Africa Budesonide Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Budesonide Market Share by Type
Table Middle East and Africa Budesonide Sales by Application (2016-2025) (MT)
Table Middle East and Africa Budesonide Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Budesonide Market Share by Application
Table Middle East and Africa Budesonide Sales by Company (2016-2018) (MT)
Table Middle East and Africa Budesonide Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Budesonide Sales Market Share by Company in 2017
Table AstraZeneca Company Details
Table AstraZeneca Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Cosmo Pharmaceuticals Company Details
Table Cosmo Pharmaceuticals Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Cosmo Pharmaceuticals Recent Development
Table Teva Company Details
Table Teva Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Teva Recent Development
Table Mylan Company Details
Table Mylan Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Mylan Recent Development
Table Sandoz Company Details
Table Sandoz Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Sandoz Recent Development
Table Dr. Falk Pharma Company Details
Table Dr. Falk Pharma Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Dr. Falk Pharma Recent Development
Table Chiesi Farmaceutici S.p.A Company Details
Table Chiesi Farmaceutici S.p.A Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Chiesi Farmaceutici S.p.A Recent Development
Table Orion Corporation Company Details
Table Orion Corporation Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Orion Corporation Recent Development
Table Cipla Company Details
Table Cipla Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Cipla Recent Development
Table Synmosa Biopharma Corporation Company Details
Table Synmosa Biopharma Corporation Budesonide Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Synmosa Biopharma Corporation Recent Development
Table Lunan Better Pharmaceutical Company Details
Table Shanghai Sine Promod Pharmaceutical Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Budesonide Value Chain
Table Typical Suppliers of Key Budesonide Raw Material
Table Budesonide Customers List
Table Budesonide Sales Channels
Table Budesonide Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *